Major domestic pharmaceutical companies are accelerating organizational restructuring by successively replacing their heads ...

If you watched the Super Bowl in 2026, you likely saw Serena Williams share her weight loss journey on GLP-1 medications in a ...

From crystallographers' beards to billion-dollar lawsuits, the phenomenon of disappearing polymorphs has puzzled chemists for decades. Now researchers are finally unravelling the science behind why st ...

The Health Products Regulatory Authority wrote to the Health Minister seeking an increase to the fees it charges to drug ...

Apotex Corp. today announced it has received the first U.S. Food and Drug Administration (FDA) Tentative Approval for its Abbreviated New Drug Application (ANDA) for Semaglutide Injection, marking a ...

Alteogen, Sam Chun Dang Pharm, and other top market capitalization biotech bellwethers on KOSDAQ are reeling from a single ...

Transfer learning can help biopharmaceutical developers to leverage historical data to guide the development of new manufacturing processes.

Do you take any medications? Nearly half of all Americans take prescription drugs (Demography, Oct. 1, 2023). Make that 85 percent of seniors (NCHS Data Brief, May 2019). Such medicines are a key ...

With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 generic drug makers are expected to begin launching their cheaper versions ...

With 90% of prescriptions in the US filled for generic drugs, there is growing concern that supplies of the medications could be in short supply due to the ongoing situation in the Strait of Hormuz, a ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...

Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on ...